Funding
Turn ideas into impact
Show Me
Due: November 16, 2026
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
US $50,000
Type
Grant
Source
Federal
Opp Number
PAR-25-370
Due: November 16, 2026
Major Research Instrumentation Program
US $100,000 – $4,000,000
Type
Grant
Source
Federal
Opp Number
23-519
Due: November 17, 2026
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-274
Due: November 17, 2026
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-158
Due: November 17, 2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-268
Due: November 17, 2026
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
US $350,000
Type
Grant
Source
Federal
Opp Number
PAR-25-267
Due: November 18, 2026
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-369
Due: November 18, 2026
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-371
Due: November 19, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer’s Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-226
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?